Gene Expression Profiling Of Cd34+/Lin- Cells Of Patients With Chronic Myeloid Leukemia At Diagnosis And After 12 Months Of Nilotinib

Alessandra Trojani,Milena Lodola,Barbara Di Camillo,Giuseppe Rossi,Adele Capucci,Alessandra Perego,Enrico Maria Pogliani,Ester Orlandi,Simona Malato,Paolo Corradini,Roberto Cairoli,Marco Bregni,Salvatore Artale,Enrica Morra,Ester Pungolino

BLOOD（2014）

引用 23|浏览20

暂无评分

摘要

Chronic myeloid leukemia (CML) is a disease of stemming from genetic damage to a hematopoietic stem cell. Despite nilotinib being a very effective drug for the treatment of CML, drug resistance can emerge.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要